International Research Peptide Customs Clearance: Documentation, Common Holds, and Resolution

Compliance & Regulation | 2026-07-09 | 10 min read

A 2026 guide to international research peptide customs clearance, covering standard documentation, the most common holds (labeling, COA, valuation, biosecurity), and resolution workflows to keep research programs on schedule.

Why most customs delays are documentation problems, not regulatory ones

Roughly 80% of research peptide customs holds are caused by incomplete or ambiguous documentation, not by an outright regulatory prohibition. A shipment that arrives with a complete documentation pack clears in 1-5 business days. The same shipment with a missing COA or an ambiguous label can sit for 10-15 business days.

Standard documentation for any international peptide shipment

Six documents cover the vast majority of international peptide clearance:

  • **Commercial invoice** — supplier name and address, buyer name and address, HS code, declared value, currency, country of origin, terms of sale (incoterms)
  • **Packing list** — vial count, lot numbers, net weight, dimensions
  • **Certificate of analysis (COA)** — per lot, with HPLC and mass spec data
  • **Material safety data sheet (MSDS)** — REACH or GHS-aligned
  • **Research-use-only declaration** — on company letterhead, signed
  • **Importer of record registration** — EORI (EU), GB EORI (UK), ABN (AU), or country equivalent

A shipment missing any one of these will face delay.

The four most common customs holds

  • **Labeling hold** — label suggests drug, supplement, or food use
  • **COA hold** — COA missing, expired, or unverifiable
  • **Valuation hold** — declared value appears too low or too high
  • **Biosecurity hold** — compound resembles a controlled or biosecurity-sensitive material

Each has a resolution workflow, but the cleanest approach is to pre-empt the hold by including the right documentation upfront.

Hold 1 — Labeling hold

A labeling hold happens when the customs officer suspects the product is intended for human consumption. Triggers include:

  • Missing or vague "research use only" statement
  • Brand language suggesting therapeutic or wellness use
  • Packaging that resembles a consumer product
  • Documentation referring to the product as a drug or supplement

Resolution: provide a clean research-use declaration on company letterhead, an updated label that removes the ambiguity, and a written confirmation that the product is for laboratory research use only.

Hold 2 — COA hold

A COA hold happens when the certificate of analysis is missing, expired, or does not match the product. Triggers include:

  • No COA in the shipment
  • COA lot number does not match vial lot number
  • COA purity claim unsupported by chromatogram
  • COA missing analyst sign-off or date

Resolution: provide a corrected COA from the supplier with proper chromatogram and analyst sign-off, or accept a replacement lot if the existing one cannot be documented.

Hold 3 — Valuation hold

A valuation hold happens when the declared value appears unusual. Triggers include:

  • Declared value significantly below market
  • Declared value significantly above market
  • Rounded values (e.g., USD 50,000 exact)
  • Inconsistent values across invoice, packing list, and COA

Resolution: provide a corrected invoice with market-aligned valuation, documentation of the underlying cost structure, and a written explanation of any unusual line items.

Hold 4 — Biosecurity hold

A biosecurity hold happens when the compound resembles a biosecurity-sensitive material. Triggers include:

  • Compound derived from animal or plant sources
  • Compound with biological activity affecting local fauna or flora
  • Compound resembling a controlled substance

Resolution: provide biosafety documentation, country-of-origin certificates, and a written confirmation of the compound's research-only use case.

The role of the importer of record

Every international shipment needs an importer of record on the buyer's side. The importer of record is the entity that:

  • Holds the country-specific registration (EORI, GB EORI, ABN, etc.)
  • Accepts responsibility for the shipment once it clears customs
  • Pays any VAT, duty, or other import tax
  • Retains customs documentation for the regulatory retention period

A peptide supplier should ask for importer of record details before shipping. A buyer without an importer of record should set one up before placing the first order.

DDP vs. DAP: choosing the right incoterm

Two incoterms work well for research peptide shipments:

  • **DDP (Delivered Duty Paid)** — the supplier pays all import costs and handles customs clearance. Simpler for the buyer but adds cost to the unit price.
  • **DAP (Delivered at Place)** — the supplier delivers to the destination but the buyer handles customs. Cheaper but more complex.

For institutional buyers with importer of record capabilities, DAP is usually cheaper. For smaller buyers without importer of record capabilities, DDP is simpler.

How ZePeptide supports customs clearance

ZePeptide prepares the standard documentation pack for every international shipment:

  • Commercial invoice and packing list per shipment
  • COA and MSDS per lot
  • Research-use declaration on letterhead
  • Country-specific import paperwork (EORI, GB EORI, ABN, etc.)
  • Cold-chain packaging validation report
  • Biosecurity pre-screening for novel compounds

Customs holds are rare. When they happen, the regulatory team coordinates with the buyer to resolve within the regulatory window.

ZePeptide content is for lawful laboratory and in-vitro research sourcing. Products are not supplied for human or veterinary use.